Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 2,213 shares at $8.10 ($18K) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $18k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.10 | 1,006 | $8K | 45.5% |
| 2 | $8.10 | 1,207 | $10K | 54.5% |
| Total | $8.10 avg | 2,213 | $18K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |